Historical source coverage

2020

170 selected records with a cited source date in 2020. This archive is selective and does not imply continuous monitoring or complete historical coverage.

Explore 2020 by record type

3 types

December 2020

21 records

Literature metadata · BPC-157

Bowel adhesion and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in rats.

PubMed lists PMID 33251034 in World journal of gastrointestinal pharmacology and therapeutics as Journal Article, with publication-date metadata of 2020-11-08 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Cetrorelix

ClinicalTrials.gov record NCT03291821

PeptideScanner retained ClinicalTrials.gov record NCT03291821 at 2026-11-15T22:02:39.332Z. Its registry update date was 2020-12-29, and PeptideScanner's reviewed identity mapping was cetrorelix.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Thymosin alpha-1

Thymosin alpha 1: A comprehensive review of the literature.

PubMed lists PMID 33362999 in World journal of virology as Journal Article, Review, with publication-date metadata of 2020-12-15 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Daptomycin

Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant Enterococcus faecium: A Focused Review of Linezolid and Daptomycin.

PubMed lists PMID 32506921 in The Annals of pharmacotherapy as Journal Article, Review, with publication-date metadata of 2020-06-08 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT03842202

PeptideScanner retained ClinicalTrials.gov record NCT03842202 at 2026-07-30T20:18:37.981Z. Its registry update date was 2020-12-24, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Pegcetacoplan

ClinicalTrials.gov record NCT03593200

PeptideScanner retained ClinicalTrials.gov record NCT03593200 at 2026-11-16T01:37:14.654Z. Its registry update date was 2020-12-22, and PeptideScanner's reviewed identity mapping was pegcetacoplan.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Desmopressin

Role of Desmopressin in the Critical Care Setting.

PubMed lists PMID 32168509 in AACN advanced critical care as Journal Article, Review, with publication-date metadata of 2020-03-15 (day precision). PeptideScanner associated the retained record with the identity slug desmopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Pasireotide

ClinicalTrials.gov record NCT00446082

PeptideScanner retained ClinicalTrials.gov record NCT00446082 at 2026-11-15T22:05:38.400Z. Its registry update date was 2020-12-21, and PeptideScanner's reviewed identity mapping was pasireotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Pasireotide

ClinicalTrials.gov record NCT00698464

PeptideScanner retained ClinicalTrials.gov record NCT00698464 at 2026-11-15T22:05:38.400Z. Its registry update date was 2020-12-21, and PeptideScanner's reviewed identity mapping was pasireotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT02220348

PeptideScanner retained ClinicalTrials.gov record NCT02220348 at 2026-07-30T20:18:37.979Z. Its registry update date was 2020-12-19, and PeptideScanner's reviewed identity mapping was linaclotide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Setmelanotide

Federal Register notice 2020-27760

The Federal Register published notice 2020-27760, attributed to FDA and its parent HHS department, on 2020-12-17. Its official title is “Issuance of Priority Review Voucher; Rare Pediatric Disease Product,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide.

Source: Federal Register via GovInfo ↗

→

Literature metadata · PEG-MGF

[Expression of mechano-growth factor in Escherichia coli and activity analysis].

PubMed lists PMID 18837392 in Sheng wu gong cheng xue bao = Chinese journal of biotechnology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-07 (month precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Triptorelin

ClinicalTrials.gov record NCT04659551

PeptideScanner retained ClinicalTrials.gov record NCT04659551 at 2026-11-15T21:49:16.513Z. Its registry update date was 2020-12-09, and PeptideScanner's reviewed identity mapping was triptorelin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Eptifibatide

The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices.

PubMed lists PMID 28621461 in Artificial organs as Journal Article, with publication-date metadata of 2017-06-16 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT03573908

PeptideScanner retained ClinicalTrials.gov record NCT03573908 at 2026-07-30T20:18:37.978Z. Its registry update date was 2020-12-01, and PeptideScanner's reviewed identity mapping was linaclotide.

Source: ClinicalTrials.gov ↗

→

November 2020

15 records

Clinical trials · Albiglutide

ClinicalTrials.gov record NCT02229227

PeptideScanner retained ClinicalTrials.gov record NCT02229227 at 2026-11-16T17:45:42.793Z. Its registry update date was 2020-11-27, and PeptideScanner's reviewed identity mapping was albiglutide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Vasopressin

Federal Register notice 2020-26133

The Federal Register published notice 2020-26133, attributed to FDA and its parent HHS department, on 2020-11-25. Its official title is “Termination of the Food and Drug Administration's Unapproved Drugs Initiative; Request for Information Regarding Drugs Potentially Generally Recognized as Safe and Effective,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

Source: Federal Register via GovInfo ↗

→

Regulatory · Setmelanotide

Drugs@FDA application NDA213793

The official Drugs@FDA dataset lists original submission 1 for NDA 213793 with status AP dated 2020-11-25, and names setmelanotide acetate among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

Clinical trials · Metreleptin

ClinicalTrials.gov record NCT02654977

PeptideScanner retained ClinicalTrials.gov record NCT02654977 at 2026-11-16T17:35:38.955Z. Its registry update date was 2020-11-24, and PeptideScanner's reviewed identity mapping was metreleptin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT04578496

PeptideScanner retained ClinicalTrials.gov record NCT04578496 at 2026-07-30T20:20:00.372Z. Its registry update date was 2020-11-19, and PeptideScanner's reviewed identity mapping was afamelanotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Glepaglutide

ClinicalTrials.gov record NCT04178447

PeptideScanner retained ClinicalTrials.gov record NCT04178447 at 2026-11-16T01:46:56.290Z. Its registry update date was 2020-11-18, and PeptideScanner's reviewed identity mapping was glepaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Nesiritide

Nesiritide in patients with acute myocardial infarction and heart failure: a meta-analysis.

PubMed lists PMID 31948318 in The Journal of international medical research as Journal Article, Meta-Analysis, with publication-date metadata of 2020-01 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · MK-677

Antiviral activity of sertindole, raloxifene and ibutamoren against transcription and replication-competent Ebola virus-like particles.

PubMed lists PMID 31964466 in BMB reports as Journal Article, with publication-date metadata of 2020-03 (month precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction: A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial.

PubMed lists PMID 32216471 in Circulation. Cardiovascular interventions as Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-03-27 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Dulaglutide

A CASE OF MORBILLIFORM DRUG ERUPTION TO DULAGLUTIDE.

PubMed lists PMID 33144906 in The Journal of clinical and aesthetic dermatology as Journal Article, with publication-date metadata of 2020-04-01 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Eptifibatide

Eptifibatide use following emergent carotid stenting in acute anterior circulation ischemic stroke with tandem occlusion.

PubMed lists PMID 32807436 in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association as Journal Article, with publication-date metadata of 2020-06-17 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

October 2020

8 records

Regulatory · Daptomycin

Federal Register notice 2020-23439

The Federal Register published notice 2020-23439, attributed to FDA and its parent HHS department, on 2020-10-22. Its official title is “21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria Web Page; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

Source: Federal Register via GovInfo ↗

→

Regulatory · Calcitonin salmon

Federal Register notice 2020-23300

The Federal Register published notice 2020-23300, attributed to FDA and its parent HHS department, on 2020-10-21. Its official title is “Determination That BUTISOL SODIUM (Butabarbital Sodium) Oral Tablets, 15 Milligrams, 50 Milligrams, and 100 Milligrams, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Calcitonin salmon.

Source: Federal Register via GovInfo ↗

→

Clinical trials · Pegcetacoplan

ClinicalTrials.gov record NCT02461771

PeptideScanner retained ClinicalTrials.gov record NCT02461771 at 2026-11-16T01:37:14.654Z. Its registry update date was 2020-10-06, and PeptideScanner's reviewed identity mapping was pegcetacoplan.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Pegcetacoplan

ClinicalTrials.gov record NCT02503332

PeptideScanner retained ClinicalTrials.gov record NCT02503332 at 2026-11-16T01:37:14.654Z. Its registry update date was 2020-10-06, and PeptideScanner's reviewed identity mapping was pegcetacoplan.

Source: ClinicalTrials.gov ↗

→

September 2020

22 records

Literature metadata · Mecasermin

Recombinant production of mecasermin in E. coli expression system.

PubMed lists PMID 26339260 in Research in pharmaceutical sciences as Journal Article, with publication-date metadata of 2014 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Calcitonin salmon

Monosialoganglioside-GM1 triggers binding of the amyloid-protein salmon calcitonin to a Langmuir membrane model mimicking the occurrence of lipid-rafts.

PubMed lists PMID 28955978 in Biochemistry and biophysics reports as Journal Article, with publication-date metadata of 2016-10-15 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Metreleptin

Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report.

PubMed lists PMID 30745727 in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology as Journal Article, with publication-date metadata of 2019-01-31 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Thymosin beta-4

Thymosin Beta 4 Is Involved in the Development of Electroacupuncture Tolerance.

PubMed lists PMID 30971892 in Frontiers in cellular neuroscience as Journal Article, with publication-date metadata of 2019-03-26 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Terlipressin

Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis.

PubMed lists PMID 31920672 in Frontiers in pharmacology as Systematic Review, Journal Article, with publication-date metadata of 2019-12-23 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Linaclotide

Linaclotide and Prucalopride for Management of Constipation in Patients with Parkinsonism.

PubMed lists PMID 30746404 in Movement disorders clinical practice as Journal Article, with publication-date metadata of 2018-01-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Selank

GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells.

PubMed lists PMID 28293190 in Frontiers in pharmacology as Journal Article, with publication-date metadata of 2017-02-28 (day precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Glatiramer acetate

Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use.

PubMed lists PMID 30775037 in Multiple sclerosis international as Journal Article, Review, with publication-date metadata of 2019-01-15 (day precision). PeptideScanner associated the retained record with the identity slug glatiramer-acetate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Eptifibatide

Tibial bypass salvage with eptifibatide in a patient with thrombocythemia.

PubMed lists PMID 31724642 in Journal of vascular surgery cases as Case Reports, Journal Article, with publication-date metadata of 2015-11-01 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Pasireotide

ClinicalTrials.gov record NCT01385956

PeptideScanner retained ClinicalTrials.gov record NCT01385956 at 2026-11-15T22:05:38.400Z. Its registry update date was 2020-09-28, and PeptideScanner's reviewed identity mapping was pasireotide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Teduglutide

Teduglutide for short bowel syndrome.

PubMed lists PMID 32346219 in Australian prescriber as Journal Article, Review, with publication-date metadata of 2020-03-03 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · LL-37

Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus.

PubMed lists PMID 32743514 in Journal of translational autoimmunity as Journal Article, Review, with publication-date metadata of 2019-12-17 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Calcitonin salmon

The Interaction between Amyloid Prefibrillar Oligomers of Salmon Calcitonin and a Lipid-Raft Model: Molecular Mechanisms Leading to Membrane Damage, Ca2+-Influx and Neurotoxicity.

PubMed lists PMID 31905804 in Biomolecules as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-12-29 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Daptomycin

ClinicalTrials.gov record NCT02972983

PeptideScanner retained ClinicalTrials.gov record NCT02972983 at 2026-11-15T22:01:45.056Z. Its registry update date was 2020-09-22, and PeptideScanner's reviewed identity mapping was daptomycin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT02563353

PeptideScanner retained ClinicalTrials.gov record NCT02563353 at 2026-07-30T20:22:36.942Z. Its registry update date was 2020-09-18, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Desmopressin

Drugs@FDA application ANDA210223

The official Drugs@FDA dataset lists original submission 1 for ANDA 210223 with status AP dated 2020-09-17, and names desmopressin acetate among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02059213

PeptideScanner retained ClinicalTrials.gov record NCT02059213 at 2026-07-30T20:22:36.939Z. Its registry update date was 2020-09-16, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Octreotide

ClinicalTrials.gov record NCT04129255

PeptideScanner retained ClinicalTrials.gov record NCT04129255 at 2026-07-30T20:22:36.942Z. Its registry update date was 2020-09-10, and PeptideScanner's reviewed identity mapping was octreotide.

Source: ClinicalTrials.gov ↗

→

August 2020

11 records

Literature metadata · Emideltide

Content of DSIP, enkephalins and ACTH in some tissues of active and hibernating ground squirrels (Citellus suslicus).

PubMed lists PMID 6132770 in Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology as Comparative Study, Journal Article, with publication-date metadata of 1983 (year precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Cerebrolysin

ClinicalTrials.gov record NCT02149875

PeptideScanner retained ClinicalTrials.gov record NCT02149875 at 2026-11-16T17:33:14.861Z. Its registry update date was 2020-08-24, and PeptideScanner's reviewed identity mapping was cerebrolysin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Pasireotide

ClinicalTrials.gov record NCT02775227

PeptideScanner retained ClinicalTrials.gov record NCT02775227 at 2026-11-15T22:05:38.400Z. Its registry update date was 2020-08-24, and PeptideScanner's reviewed identity mapping was pasireotide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Bremelanotide

Federal Register notice 2020-18240

The Federal Register published notice 2020-18240, attributed to FDA and its parent HHS department, on 2020-08-20. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; VYLEESI,” and PeptideScanner's exact reviewed identity mapping connects the document to Bremelanotide.

Source: Federal Register via GovInfo ↗

→

Clinical trials · Plecanatide

ClinicalTrials.gov record NCT02706483

PeptideScanner retained ClinicalTrials.gov record NCT02706483 at 2026-07-30T20:24:11.156Z. Its registry update date was 2020-08-18, and PeptideScanner's reviewed identity mapping was plecanatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Trofinetide

ClinicalTrials.gov record NCT02715115

PeptideScanner retained ClinicalTrials.gov record NCT02715115 at 2026-11-15T21:57:22.404Z. Its registry update date was 2020-08-14, and PeptideScanner's reviewed identity mapping was trofinetide.

Source: ClinicalTrials.gov ↗

→

July 2020

8 records

Regulatory · Vasopressin

Federal Register notice 2020-16649

The Federal Register published notice 2020-16649, attributed to FDA and its parent HHS department, on 2020-07-31. Its official title is “List of Bulk Drug Substances for Which There is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

Source: Federal Register via GovInfo ↗

→

Regulatory · Terlipressin

Federal Register notice 2020-14719

The Federal Register published notice 2020-14719, attributed to FDA and its parent HHS department, on 2020-07-08. Its official title is “Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Terlipressin.

Source: Federal Register via GovInfo ↗

→

Literature metadata · BPC-157

An endogeous defensive concept, renewed cytoprotection/adaptive cytoprotection: intra(per)-oral/intragastric strong alcohol in rat. Involvement of pentadecapeptide BPC 157 and nitric oxide system.

PubMed lists PMID 30279308 in Journal of physiology and pharmacology : an official journal of the Polish Physiological Society as Journal Article, with publication-date metadata of 2018-09-28 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

June 2020

10 records

Literature metadata · Bremelanotide

PubMed record PMID 31277966

PeptideScanner retained PubMed bibliographic metadata for PMID 31277966 at 2026-07-30T20:27:29.445Z. PubMed recorded a metadata revision date of 2020-06-29 and an Entrez history date of 2019-07-07. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Degarelix

Prostate Cancer Drug Degarelix Rapidly Treats Pedophilic Disorder.

PubMed lists PMID 32573666 in JAMA as Journal Article, with publication-date metadata of 2020-06-23 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · MOTS-c

A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome.

PubMed lists PMID 31088495 in Journal of translational medicine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-05-14 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Glatiramer acetate

Comparison of Copaxone® and Synthon's therapeutically equivalent glatiramer acetate.

PubMed lists PMID 31526436 in Die Pharmazie as Journal Article, Review, with publication-date metadata of 2019-08-01 (day precision). PeptideScanner associated the retained record with the identity slug glatiramer-acetate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

May 2020

18 records

Literature metadata · Teduglutide

Accelerated Colorectal Polyposis in an Immunosuppressed Patient With a Small Bowel Transplant Treated With Teduglutide: Case Report and Review of Literature.

PubMed lists PMID 31176580 in Clinical colorectal cancer as Case Reports, Journal Article, Review, with publication-date metadata of 2019-03-11 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Dulaglutide

Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7).

PubMed lists PMID 30762290 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-03-29 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Afamelanotide

PubMed record PMID 32459219

PeptideScanner retained PubMed bibliographic metadata for PMID 32459219 at 2026-07-30T20:28:46.334Z. PubMed recorded a metadata revision date of 2020-05-29 and an Entrez history date of 2020-05-28. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Difelikefalin

Difelikefalin in Hemodialysis Patients with Pruritus. Reply.

PubMed lists PMID 32433848 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2020-05-21 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Nesiritide

Federal Register notice 2020-10367

The Federal Register published notice 2020-10367, attributed to FDA and its parent HHS department, on 2020-05-14. Its official title is “Janssen Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 16 New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Nesiritide.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Daptomycin

Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia.

PubMed lists PMID 31284042 in International journal of antimicrobial agents as Journal Article, Meta-Analysis, with publication-date metadata of 2019-07-05 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Dulaglutide

Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report.

PubMed lists PMID 31823494 in Geriatrics & gerontology international as Case Reports, Letter, with publication-date metadata of 2019-12 (month precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pasireotide

How to Position Pasireotide LAR Treatment in Acromegaly.

PubMed lists PMID 30608534 in The Journal of clinical endocrinology and metabolism as Journal Article, Review, with publication-date metadata of 2019-06-01 (day precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Teduglutide

Teduglutide in Patients With Active Crohn's Disease and Short Bowel Syndrome.

PubMed lists PMID 30990222 in Inflammatory bowel diseases as Case Reports, Letter, with publication-date metadata of 2019-08-20 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

April 2020

13 records

Literature metadata · Metreleptin

Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes.

PubMed lists PMID 31300002 in Orphanet journal of rare diseases as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-07-12 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Plecanatide

PubMed record PMID 30277094

PeptideScanner retained PubMed bibliographic metadata for PMID 30277094 at 2026-07-30T20:30:10.458Z. PubMed recorded a metadata revision date of 2020-04-27 and an Entrez history date of 2018-10-03. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Terlipressin

ClinicalTrials.gov record NCT04358016

PeptideScanner retained ClinicalTrials.gov record NCT04358016 at 2026-11-15T21:47:40.408Z. Its registry update date was 2020-04-22, and PeptideScanner's reviewed identity mapping was terlipressin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Thymopentin

Tetrahydro-β-carboline-3-carboxyl-thymopentin: a nano-conjugate for releasing pharmacophores to treat tumor and complications.

PubMed lists PMID 32263105 in Journal of materials chemistry. B as Journal Article, with publication-date metadata of 2015-12-24 (day precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Tesamorelin

PubMed record PMID 31237318

PeptideScanner retained PubMed bibliographic metadata for PMID 31237318 at 2026-07-30T20:30:10.504Z. PubMed recorded a metadata revision date of 2020-04-07 and an Entrez history date of 2019-06-26. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

March 2020

18 records

Clinical trials · Dasiglucagon

ClinicalTrials.gov record NCT03984370

PeptideScanner retained ClinicalTrials.gov record NCT03984370 at 2026-11-16T01:42:39.027Z. Its registry update date was 2020-03-31, and PeptideScanner's reviewed identity mapping was dasiglucagon.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Terlipressin

Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence.

PubMed lists PMID 30474439 in Current medical research and opinion as Journal Article, Review, with publication-date metadata of 2019-01-04 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Icatibant

Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B2 Receptor Antagonist Icatibant Are G Protein Biased Agonists for MRGPRX2 in Mast Cells.

PubMed lists PMID 30651343 in Journal of immunology (Baltimore, Md. : 1950) as Journal Article, Research Support, N.I.H., Extramural, with publication-date metadata of 2019-01-16 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Plecanatide

PubMed record PMID 30649746

PeptideScanner retained PubMed bibliographic metadata for PMID 30649746 at 2026-07-30T20:31:47.875Z. PubMed recorded a metadata revision date of 2020-03-09 and an Entrez history date of 2019-01-17. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Humanin

Mitochondrial-derived peptide humanin as therapeutic target in cancer and degenerative diseases.

PubMed lists PMID 30582721 in Expert opinion on therapeutic targets as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2018-12-24 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Afamelanotide

PubMed record PMID 28063031

PeptideScanner retained PubMed bibliographic metadata for PMID 28063031 at 2026-07-30T20:31:47.806Z. PubMed recorded a metadata revision date of 2020-03-06 and an Entrez history date of 2017-01-08. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Calcitonin salmon

Ultrasound parameters in osteoporotic patients treated with salmon calcitonin: a longitudinal study.

PubMed lists PMID 8883119 in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1996 (year precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Efinopegdutide

ClinicalTrials.gov record NCT03606057

PeptideScanner retained ClinicalTrials.gov record NCT03606057 at 2026-11-16T17:46:45.897Z. Its registry update date was 2020-03-03, and PeptideScanner's reviewed identity mapping was efinopegdutide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Liraglutide + 1 more

Federal Register notice 2020-04320

The Federal Register published notice 2020-04320, attributed to FDA and its parent HHS department, on 2020-03-03. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide and Semaglutide.

Source: Federal Register via GovInfo ↗

→

February 2020

13 records

Literature metadata · Lixisenatide

PubMed record PMID 31873867

PeptideScanner retained PubMed bibliographic metadata for PMID 31873867 at 2026-07-30T20:33:08.013Z. PubMed recorded a metadata revision date of 2020-02-26 and an Entrez history date of 2019-12-25. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Secretin

Distribution and Functional Implication of Secretin in Multiple Brain Regions.

PubMed lists PMID 29882022 in Journal of molecular neuroscience : MN as Journal Article, Review, with publication-date metadata of 2018-06-07 (day precision). PeptideScanner associated the retained record with the identity slug secretin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis of CTB-001, a Recently Developed Generic of Bivalirudin.

PubMed lists PMID 31396727 in Pharmaceutical research as Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2019-08-08 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bremelanotide

PubMed record PMID 31429064

PeptideScanner retained PubMed bibliographic metadata for PMID 31429064 at 2026-07-30T20:33:07.992Z. PubMed recorded a metadata revision date of 2020-02-25 and an Entrez history date of 2019-08-21. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Octreotide

ClinicalTrials.gov record NCT04281680

PeptideScanner retained ClinicalTrials.gov record NCT04281680 at 2026-07-30T20:32:04.760Z. Its registry update date was 2020-02-24, and PeptideScanner's reviewed identity mapping was octreotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04175665

PeptideScanner retained ClinicalTrials.gov record NCT04175665 at 2026-07-30T20:32:04.760Z. Its registry update date was 2020-02-21, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Glatiramer acetate

ClinicalTrials.gov record NCT00203021

PeptideScanner retained ClinicalTrials.gov record NCT00203021 at 2026-11-16T17:42:50.457Z. Its registry update date was 2020-02-18, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.

Source: ClinicalTrials.gov ↗

→

Regulatory · Desmopressin

Drugs@FDA application ANDA210218

The official Drugs@FDA dataset lists original submission 1 for ANDA 210218 with status AP dated 2020-02-14, and names desmopressin acetate among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

Clinical trials · Metreleptin

ClinicalTrials.gov record NCT00657605

PeptideScanner retained ClinicalTrials.gov record NCT00657605 at 2026-11-16T17:35:38.955Z. Its registry update date was 2020-02-13, and PeptideScanner's reviewed identity mapping was metreleptin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Metreleptin

ClinicalTrials.gov record NCT00659828

PeptideScanner retained ClinicalTrials.gov record NCT00659828 at 2026-11-16T17:35:38.955Z. Its registry update date was 2020-02-13, and PeptideScanner's reviewed identity mapping was metreleptin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02351232

PeptideScanner retained ClinicalTrials.gov record NCT02351232 at 2026-07-30T20:32:04.755Z. Its registry update date was 2020-02-12, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Etelcalcetide

ClinicalTrials.gov record NCT03283098

PeptideScanner retained ClinicalTrials.gov record NCT03283098 at 2026-11-15T22:07:29.454Z. Its registry update date was 2020-02-10, and PeptideScanner's reviewed identity mapping was etelcalcetide.

Source: ClinicalTrials.gov ↗

→

January 2020

13 records

Literature metadata · GHK-Cu

PubMed record PMID 31500015

PeptideScanner retained PubMed bibliographic metadata for PMID 31500015 at 2026-07-30T20:34:13.000Z. PubMed recorded a metadata revision date of 2020-01-28 and an Entrez history date of 2019-09-11. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Desmopressin

Perioperative Desmopressin for Patients Undergoing Otolaryngologic Procedures: A Systematic Review.

PubMed lists PMID 30857487 in Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery as Journal Article, Systematic Review, with publication-date metadata of 2019-03-12 (day precision). PeptideScanner associated the retained record with the identity slug desmopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Triptorelin

ClinicalTrials.gov record NCT03115307

PeptideScanner retained ClinicalTrials.gov record NCT03115307 at 2026-11-15T21:49:16.513Z. Its registry update date was 2020-01-27, and PeptideScanner's reviewed identity mapping was triptorelin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Difelikefalin

Difelikefalin for the Treatment of Uremic Pruritus.

PubMed lists PMID 31940704 in The New England journal of medicine as Editorial, Comment, with publication-date metadata of 2020-01-16 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT02196831

PeptideScanner retained ClinicalTrials.gov record NCT02196831 at 2026-07-30T20:33:20.623Z. Its registry update date was 2020-01-27, and PeptideScanner's reviewed identity mapping was tesamorelin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · GHK-Cu

PubMed record PMID 31809714

PeptideScanner retained PubMed bibliographic metadata for PMID 31809714 at 2026-07-30T20:34:13.013Z. PubMed recorded a metadata revision date of 2020-01-23 and an Entrez history date of 2019-12-07. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Dalbavancin

ClinicalTrials.gov record NCT03233438

PeptideScanner retained ClinicalTrials.gov record NCT03233438 at 2026-11-16T17:37:42.807Z. Its registry update date was 2020-01-18, and PeptideScanner's reviewed identity mapping was dalbavancin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · CJC-1295

PubMed record PMID 30938069

PeptideScanner retained PubMed bibliographic metadata for PMID 30938069 at 2026-07-30T20:34:12.987Z. PubMed recorded a metadata revision date of 2020-01-13 and an Entrez history date of 2019-04-03. PeptideScanner associated this retained record with the identity slug cjc-1295. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Plecanatide

PubMed record PMID 30550753

PeptideScanner retained PubMed bibliographic metadata for PMID 30550753 at 2026-07-30T20:34:12.979Z. PubMed recorded a metadata revision date of 2020-01-07 and an Entrez history date of 2018-12-15. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→